View in EDS

Combined DMT-harmine formulation reduces negative self-referential emotions during social self-evaluation: a randomized placebo-controlled trial in healthy volunteers.

Saved in:
Bibliographic Details
Title: Combined DMT-harmine formulation reduces negative self-referential emotions during social self-evaluation: a randomized placebo-controlled trial in healthy volunteers.
Authors: Aicher HD; Psychedelic Research & Therapy Development, Department of Adult Psychiatry and Psychotherapy, University Hospital of Psychiatry Zurich, University of Zurich, Lenggstrasse 31, P.O. Box 363, CH-8032, Zurich, Switzerland. helena.aicher@uzh.ch.; Department of Psychology, University of Zurich, Zurich, Switzerland. helena.aicher@uzh.ch.; Experimental Pharmacopsychology and Psychological Addiction Research, Department of Adult Psychiatry and Psychotherapy, University Hospital of Psychiatry Zurich, University of Zurich, Zurich, Switzerland. helena.aicher@uzh.ch., Dornbierer J; Psychedelic Research & Therapy Development, Department of Adult Psychiatry and Psychotherapy, University Hospital of Psychiatry Zurich, University of Zurich, Lenggstrasse 31, P.O. Box 363, CH-8032, Zurich, Switzerland. joellealine.dornbierer@uzh.ch.; Neuroscience Center Zurich (ZNZ), University of Zurich and ETH Zurich, Zurich, Switzerland. joellealine.dornbierer@uzh.ch., Caflisch L; Psychedelic Research & Therapy Development, Department of Adult Psychiatry and Psychotherapy, University Hospital of Psychiatry Zurich, University of Zurich, Lenggstrasse 31, P.O. Box 363, CH-8032, Zurich, Switzerland.; Department of Psychology, University of Zurich, Zurich, Switzerland., Suay D; Psychedelic Research & Therapy Development, Department of Adult Psychiatry and Psychotherapy, University Hospital of Psychiatry Zurich, University of Zurich, Lenggstrasse 31, P.O. Box 363, CH-8032, Zurich, Switzerland.; MoMiLab, IMT School for Advanced Studies, Lucca, Italy., Mueller MJ; Psychedelic Research & Therapy Development, Department of Adult Psychiatry and Psychotherapy, University Hospital of Psychiatry Zurich, University of Zurich, Lenggstrasse 31, P.O. Box 363, CH-8032, Zurich, Switzerland., Landolt HP; Neuroscience Center Zurich (ZNZ), University of Zurich and ETH Zurich, Zurich, Switzerland.; Institute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland., Quednow BB; Experimental Pharmacopsychology and Psychological Addiction Research, Department of Adult Psychiatry and Psychotherapy, University Hospital of Psychiatry Zurich, University of Zurich, Zurich, Switzerland.; Neuroscience Center Zurich (ZNZ), University of Zurich and ETH Zurich, Zurich, Switzerland., Scheidegger M; Psychedelic Research & Therapy Development, Department of Adult Psychiatry and Psychotherapy, University Hospital of Psychiatry Zurich, University of Zurich, Lenggstrasse 31, P.O. Box 363, CH-8032, Zurich, Switzerland., Dornbierer D; Psychedelic Research & Therapy Development, Department of Adult Psychiatry and Psychotherapy, University Hospital of Psychiatry Zurich, University of Zurich, Lenggstrasse 31, P.O. Box 363, CH-8032, Zurich, Switzerland.
Source: Psychopharmacology [Psychopharmacology (Berl)] 2026 Jul 14. Date of Electronic Publication: 2026 Jul 14.
Publication Type: Journal Article
Journal Info: Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 7608025 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-2072 (Electronic) Linking ISSN: 00333158 NLM ISO Abbreviation: Psychopharmacology (Berl) Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42443620
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Combined DMT-harmine formulation reduces negative self-referential emotions during social self-evaluation: a randomized placebo-controlled trial in healthy volunteers.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Aicher+HD%22">Aicher HD</searchLink>; Psychedelic Research & Therapy Development, Department of Adult Psychiatry and Psychotherapy, University Hospital of Psychiatry Zurich, University of Zurich, Lenggstrasse 31, P.O. Box 363, CH-8032, Zurich, Switzerland. helena.aicher@uzh.ch.; Department of Psychology, University of Zurich, Zurich, Switzerland. helena.aicher@uzh.ch.; Experimental Pharmacopsychology and Psychological Addiction Research, Department of Adult Psychiatry and Psychotherapy, University Hospital of Psychiatry Zurich, University of Zurich, Zurich, Switzerland. helena.aicher@uzh.ch.<br /><searchLink fieldCode="AU" term="%22Dornbierer+J%22">Dornbierer J</searchLink>; Psychedelic Research & Therapy Development, Department of Adult Psychiatry and Psychotherapy, University Hospital of Psychiatry Zurich, University of Zurich, Lenggstrasse 31, P.O. Box 363, CH-8032, Zurich, Switzerland. joellealine.dornbierer@uzh.ch.; Neuroscience Center Zurich (ZNZ), University of Zurich and ETH Zurich, Zurich, Switzerland. joellealine.dornbierer@uzh.ch.<br /><searchLink fieldCode="AU" term="%22Caflisch+L%22">Caflisch L</searchLink>; Psychedelic Research & Therapy Development, Department of Adult Psychiatry and Psychotherapy, University Hospital of Psychiatry Zurich, University of Zurich, Lenggstrasse 31, P.O. Box 363, CH-8032, Zurich, Switzerland.; Department of Psychology, University of Zurich, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Suay+D%22">Suay D</searchLink>; Psychedelic Research & Therapy Development, Department of Adult Psychiatry and Psychotherapy, University Hospital of Psychiatry Zurich, University of Zurich, Lenggstrasse 31, P.O. Box 363, CH-8032, Zurich, Switzerland.; MoMiLab, IMT School for Advanced Studies, Lucca, Italy.<br /><searchLink fieldCode="AU" term="%22Mueller+MJ%22">Mueller MJ</searchLink>; Psychedelic Research & Therapy Development, Department of Adult Psychiatry and Psychotherapy, University Hospital of Psychiatry Zurich, University of Zurich, Lenggstrasse 31, P.O. Box 363, CH-8032, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Landolt+HP%22">Landolt HP</searchLink>; Neuroscience Center Zurich (ZNZ), University of Zurich and ETH Zurich, Zurich, Switzerland.; Institute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Quednow+BB%22">Quednow BB</searchLink>; Experimental Pharmacopsychology and Psychological Addiction Research, Department of Adult Psychiatry and Psychotherapy, University Hospital of Psychiatry Zurich, University of Zurich, Zurich, Switzerland.; Neuroscience Center Zurich (ZNZ), University of Zurich and ETH Zurich, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Scheidegger+M%22">Scheidegger M</searchLink>; Psychedelic Research & Therapy Development, Department of Adult Psychiatry and Psychotherapy, University Hospital of Psychiatry Zurich, University of Zurich, Lenggstrasse 31, P.O. Box 363, CH-8032, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Dornbierer+D%22">Dornbierer D</searchLink>; Psychedelic Research & Therapy Development, Department of Adult Psychiatry and Psychotherapy, University Hospital of Psychiatry Zurich, University of Zurich, Lenggstrasse 31, P.O. Box 363, CH-8032, Zurich, Switzerland.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227608025%22">Psychopharmacology</searchLink> [Psychopharmacology (Berl)] 2026 Jul 14. <i>Date of Electronic Publication: </i>2026 Jul 14.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer-Verlag%22">Springer-Verlag </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>7608025 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1432-2072 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200333158%22">00333158 </searchLink><i>NLM ISO Abbreviation: </i>Psychopharmacology (Berl) <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42443620
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s00213-026-07118-4
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Combined DMT-harmine formulation reduces negative self-referential emotions during social self-evaluation: a randomized placebo-controlled trial in healthy volunteers.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Aicher HD
      – PersonEntity:
          Name:
            NameFull: Dornbierer J
      – PersonEntity:
          Name:
            NameFull: Caflisch L
      – PersonEntity:
          Name:
            NameFull: Suay D
      – PersonEntity:
          Name:
            NameFull: Mueller MJ
      – PersonEntity:
          Name:
            NameFull: Landolt HP
      – PersonEntity:
          Name:
            NameFull: Quednow BB
      – PersonEntity:
          Name:
            NameFull: Scheidegger M
      – PersonEntity:
          Name:
            NameFull: Dornbierer D
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 14
              M: 07
              Text: 2026 Jul 14
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1432-2072
          Titles:
            – TitleFull: Psychopharmacology
              Type: main
ResultId 1